Adfrar 40mg Adalimumab Injection

Adfrar 40mg Adalimumab Injection is a prescription biologic medication used to treat various autoimmune and inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, and hidradenitis suppurativa. It contains Adalimumab, a monoclonal antibody that works by blocking tumor necrosis factor-alpha (TNF-α), a protein that contributes to inflammation and immune system overactivity. By reducing inflammation, Adfrar 40mg Adalimumab Injection helps relieve symptoms, improve physical function, and support long-term disease control. Administered as a subcutaneous injection under the guidance of a healthcare professional, it requires regular monitoring to evaluate treatment effectiveness and manage potential side effects. Patients should use Adfrar 40mg Injection only as prescribed by their healthcare provider.